SHE:000153

2 stories mentioning SHE:000153Updated 50d ago

Every FINWIRES story that references SHE:000153, newest first.

Fengyuan Pharma's Unit Gets Nod for Marketing of Vonoprazan Fumarate

Anhui Fengyuan Pharmaceutical's (SHE:000153) unit, Bengbu Fengyuan Tushan Pharmaceutical, obtained approval from China's National Medical Products Administration for the marketing of vonoprazan fumarate, according to a Shenzhen bourse filing on Wednesday.The chemical raw material was developed for the treatment of reflux esophagitis and Helicobacter pylori infection.

SHE:000153

Asia55d ago

Anhui Fengyuan Pharmaceutical Gets China Regulatory Approval for Pediatric Constipation Drug

Anhui Fengyuan Pharmaceutical (SHE:000153) obtained drug registration from China's medical products regulator for its compound polyethylene glycol and electrolytes powder.The prescription powder is indicated for treating chronic constipation in children, according to a Friday filing with the Shenzhen bourse.The approval is valid until April 28, 2031.Shares of the company closed 1% higher Friday.

SHE:000153

Track with the FINWIRES app suite

FolioX

Track SHE:000153 in your portfolio

WheelAI

Analyze SHE:000153 options with the wheel strategy

StockInsider

See market sentiment on SHE:000153